Get the Stockscreener App
1.20
0.84%
0.01
Allarity Therapeutics Inc stock is traded at $1.20, with a volume of 50,447.
It is up +0.84% in the last 24 hours and up +12.15% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.19
Open:
$1.18
24h Volume:
50,447
Relative Volume:
0.29
Market Cap:
$19.27M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00582
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
+3.45%
1M Performance:
+12.15%
6M Performance:
+17.65%
1Y Performance:
-22.08%
1-Day Range:
$1.18
$1.21
1-Week Range:
$1.13
$1.265
52-Week Range:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.20 | 19.11M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
Activity Recap: Will Advanced Flower Capital Inc benefit from rising consumer demand2025 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
Can Allarity Therapeutics Inc disrupt its industryMarket Activity Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Short Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Declines By 17.1% - Defense World
Aug EndMonth: Is Allarity Therapeutics Inc backed by strong institutional buying2025 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
Can Allarity Therapeutics Inc expand its profit margins2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Published on: 2026-01-16 10:01:32 - baoquankhu1.vn
Published on: 2026-01-16 08:05:07 - baoquankhu1.vn
Meme Stocks: Is Yuanbao Inc Depositary Receipt stock influenced by commodity pricesJuly 2025 Gainers & Reliable Price Action Trade Plans - baoquankhu1.vn
Market Outlook: What valuation multiples suggest for Allarity Therapeutics Inc stockJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Bộ Nội Vụ
EV Market: Can Allarity Therapeutics Inc keep up with sector leadersProfit Target & Weekly Return Optimization Alerts - baoquankhu1.vn
Loss Report: Can Allarity Therapeutics Inc stock maintain growth trajectoryShare Buyback & Stepwise Trade Execution Plans - Bộ Nội Vụ
Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO) - Defense World
Market Wrap: What dividend safety score for Allarity Therapeutics Inc stockQuarterly Performance Summary & Technical Confirmation Alerts - Bộ Nội Vụ
What catalysts could drive Allarity Therapeutics Inc. stock higherJuly 2025 Weekly Recap & Weekly High Momentum Picks - Улправда
Allarity Therapeutics, Inc.Common stock (NQ: ALLR - FinancialContent
How Allarity Therapeutics Inc. stock benefits from tech adoptionMarket Risk Report & Growth Oriented Trade Recommendations - ulpravda.ru
How strong is Allarity Therapeutics Inc. stock balance sheetPrice Support Zones & Free Tap Rapid Wealth - Улправда
News | postregister.comAllarity Therapeutics, Inc.Common stock (Nasdaq:ALLR) Price Chart - FinancialContent
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus
Is Allarity Therapeutics Inc. stock a buy before product launches2026 world cup usa national team qualification young talents high defensive line winner prediction guide - ulpravda.ru
Allarity CEO says 2026 represents an ‘inflection point’ - Yahoo Finance
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders - GlobeNewswire
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Down 21.9% in December - Defense World
Allarity Therapeutics Completes Additional Private Equity Financing - TipRanks
ALLR DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR - Macau Business
How Allarity Therapeutics Inc. stock reacts to Fed rate cutsEarnings Overview Summary & Smart Investment Allocation Tips - Улправда
Is Allarity Therapeutics Inc. stock oversold or undervalued2025 Stock Rankings & Smart Allocation Stock Tips - Улправда
Hedge Fund Bets: How Allarity Therapeutics Inc. stock reacts to Fed rate cuts2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
Will Allarity Therapeutics Inc. stock maintain dividend yieldJuly 2025 Final Week & High Conviction Investment Ideas - DonanımHaber
Is Allarity Therapeutics Inc. stock a bargain at current levels2025 Sector Review & Verified Stock Trade Ideas - Улправда
Published on: 2025-12-19 05:31:28 - Улправда
Allarity Therapeutics Earnings Notes - Trefis
Allarity Therapeutics Secures $2.5M Through Private Placement - MSN
Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq
ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rati - GuruFocus
Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks
Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com
Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser
Will Allarity Therapeutics Inc. stock return to pre crisis levelsPortfolio Update Report & High Yield Stock Recommendations - Newser
Can Allarity Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Allarity Therapeutics Inc to offer up to $50 million in securities - marketscreener.com
How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Published on: 2025-11-28 11:27:30 - Bộ Nội Vụ
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Allarity Therapeutics Inc. (ALLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Metastatic Breast Cancer Pipeline Insights Report 2025: Uncovering Breakthrough Drug Candidates Driving Future Market Growth - The Globe and Mail
Allarity Therapeutics, Inc. (ALLR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is it too late to sell Allarity Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com
How Allarity Therapeutics Inc. stock performs in weak economyShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):